Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Owen

Showing results (131-140 of 163) with videos related to

Pageof 17
Sort By:
Brain, Behavior, and Immunity|March 18, 2018
VEGFR2 promotes central endothelial activation and the spread of pain in inflammatory arthritisNicholas Beazley-Long, Daryl Hodge, William Robert Ashby, et al.
BMC Nephrology|August 8, 2015
Update: Rationale and design of the Sodium Lowering In Dialysate (SoLID) trial: a randomised controlled trial of low versus standard dialysate sodium concentration during hemodialysis for regression of left ventricular massJoanna Leigh Dunlop, Alain Charles Vandal, Janak Rashme de Zoysa, et al.
BMC Nephrology|July 17, 2013
Rationale and design of the Sodium Lowering In Dialysate (SoLID) trial: a randomised controlled trial of low versus standard dialysate sodium concentration during hemodialysis for regression of left ventricular massJoanna Leigh Dunlop, Alain Charles Vandal, Janak Rashme de Zoysa, et al.
BMJ (Clinical Research Ed.)|February 4, 2010
Homoeopathy debate. Editorial ignores evidencePeter A Fisher, Robert T Mathie, David Owen, et al.
Bulletin of the Chemical Society of Japan|June 3, 2024
Cyclic β<sup>2,3</sup>-amino acids improve the serum stability of macrocyclic peptide inhibitors targeting the SARS-CoV-2 main proteaseTakashi Miura, Tika R Malla, Lennart Brewitz, et al.
Cellular and Molecular Life Sciences : CMLS|April 26, 2020
Fucosidases from the human gut symbiont Ruminococcus gnavusHaiyang Wu, Osmond Rebello, Emmanuelle H Crost, et al.
Chemical Communications (Cambridge, England)|January 19, 2021
Mass spectrometry reveals potential of β-lactams as SARS-CoV-2 M<sup>pro</sup> inhibitorsTika R Malla, Anthony Tumber, Tobias John, et al.
Cell Chemical Biology|June 26, 2021
An automatic pipeline for the design of irreversible derivatives identifies a potent SARS-CoV-2 M<sup>pro</sup> inhibitorDaniel Zaidman, Paul Gehrtz, Mihajlo Filep, et al.
Nature Chemistry|May 22, 2023
In vitro selection of macrocyclic peptide inhibitors containing cyclic γ<sup>2,4</sup>-amino acids targeting the SARS-CoV-2 main proteaseTakashi Miura, Tika R Malla, C David Owen, et al.
ACS Central Science|September 2, 2024
Cryo-tomography and 3D Electron Diffraction Reveal the Polar Habit and Chiral Structure of the Malaria Pigment Crystal HemozoinPaul Benjamin Klar, David Geoffrey Waterman, Tim Gruene, et al.
Pageof 17

Showing results (131-140 of 163) with videos related to

Sort By:
Pageof 17
Brain, Behavior, and Immunity|March 18, 2018
VEGFR2 promotes central endothelial activation and the spread of pain in inflammatory arthritisNicholas Beazley-Long, Daryl Hodge, William Robert Ashby, et al.
BMC Nephrology|August 8, 2015
Update: Rationale and design of the Sodium Lowering In Dialysate (SoLID) trial: a randomised controlled trial of low versus standard dialysate sodium concentration during hemodialysis for regression of left ventricular massJoanna Leigh Dunlop, Alain Charles Vandal, Janak Rashme de Zoysa, et al.
BMC Nephrology|July 17, 2013
Rationale and design of the Sodium Lowering In Dialysate (SoLID) trial: a randomised controlled trial of low versus standard dialysate sodium concentration during hemodialysis for regression of left ventricular massJoanna Leigh Dunlop, Alain Charles Vandal, Janak Rashme de Zoysa, et al.
BMJ (Clinical Research Ed.)|February 4, 2010
Homoeopathy debate. Editorial ignores evidencePeter A Fisher, Robert T Mathie, David Owen, et al.
Bulletin of the Chemical Society of Japan|June 3, 2024
Cyclic β<sup>2,3</sup>-amino acids improve the serum stability of macrocyclic peptide inhibitors targeting the SARS-CoV-2 main proteaseTakashi Miura, Tika R Malla, Lennart Brewitz, et al.
Cellular and Molecular Life Sciences : CMLS|April 26, 2020
Fucosidases from the human gut symbiont Ruminococcus gnavusHaiyang Wu, Osmond Rebello, Emmanuelle H Crost, et al.
Chemical Communications (Cambridge, England)|January 19, 2021
Mass spectrometry reveals potential of β-lactams as SARS-CoV-2 M<sup>pro</sup> inhibitorsTika R Malla, Anthony Tumber, Tobias John, et al.
Cell Chemical Biology|June 26, 2021
An automatic pipeline for the design of irreversible derivatives identifies a potent SARS-CoV-2 M<sup>pro</sup> inhibitorDaniel Zaidman, Paul Gehrtz, Mihajlo Filep, et al.
Nature Chemistry|May 22, 2023
In vitro selection of macrocyclic peptide inhibitors containing cyclic γ<sup>2,4</sup>-amino acids targeting the SARS-CoV-2 main proteaseTakashi Miura, Tika R Malla, C David Owen, et al.
ACS Central Science|September 2, 2024
Cryo-tomography and 3D Electron Diffraction Reveal the Polar Habit and Chiral Structure of the Malaria Pigment Crystal HemozoinPaul Benjamin Klar, David Geoffrey Waterman, Tim Gruene, et al.
Pageof 17